Mainz Biomed (NASDAQ:MYNZ – Get Rating) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 28,300 shares, a drop of 28.4% from the May 15th total of 39,500 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average trading volume […]
Mainz Biomed (NASDAQ:MYNZ – Get Rating) saw a significant drop in short interest in May. As of May 31st, there was short interest totalling 28,300 shares, a drop of 28.4% from the May 15th total of 39,500 shares. Currently, 0.3% of the shares of the stock are short sold. Based on an average trading volume […]
Mainz Biomed (NASDAQ:MYNZ – Get Rating) – Equities researchers at Cantor Fitzgerald increased their FY2023 earnings per share (EPS) estimates for shares of Mainz Biomed in a research note issued to investors on Thursday, May 18th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will earn ($1.02) per share for the year, up […]
Mainz Biomed (NASDAQ:MYNZ – Get Rating) – Analysts at HC Wainwright boosted their Q2 2023 earnings per share (EPS) estimates for Mainz Biomed in a note issued to investors on Tuesday, May 16th. HC Wainwright analyst Y. Chen now expects that the company will post earnings per share of ($0.44) for the quarter, up from […]
Mainz Biomed (NASDAQ:MYNZ – Get Rating) was the target of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 12,800 shares, a decrease of 67.0% from the April 15th total of 38,800 shares. Approximately 0.1% of the company’s shares are short sold. Based on […]